atopic dermatitis

News

Woman with vitiligo crosses her arms in front of her chest

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

Pfizer's JAK inhibitor Litfulo hits the mark in vitiligo, setting up filings, as Incyte claims EU approval for Opzelura in atopic dermatitis.

News

Sanofi gives up on amlitelimab in atopic dermatitis

Sanofi has stopped development of anti-OX40L drug amlitelimab in atopic dermatitis, a major blow to what was once viewed as a 'pipeline-in-a-product'.

News

Lilly wins new FDA approval for eczema drug Ebglyss

Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.

News

Sanofi's bispecific lunsekimig has mixed readouts in phase 2

Sanofi's IL-13 and TSLP-targeting bispecific lunsekimig wins two, loses one, in readouts from its midstage clinical trials programme.

News

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug

Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in patients taking the drug.

News

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

Sanofi gives up on amlitelimab in atopic dermatitis

Lilly wins new FDA approval for eczema drug Ebglyss

Sanofi's bispecific lunsekimig has mixed readouts in phase 2

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug

MSD and Mayo Clinic team up on AI drug discovery

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

atopic dermatitis

Editor's Picks